All News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:36:42 2024-06-10 am EDT			After market 03:59:59 pm
90.27 ^EUR	-0.94%		90.4	+0.14%

12:30pm	Moderna COVID/flu combo vaccine superior to separate shots in trial	RE
Jun. 06	Ipsen Hires New Chief Corporate Affairs Officer	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Moderna COVID/flu combo vaccine superior to separate shots in trial	06:30am	RE
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	Jun. 07	AQ
Ipsen Hires New Chief Corporate Affairs Officer	Jun. 06	MT
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development	Jun. 06	AQ
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada	Jun. 05	MT
Lupin Atlantis Holdings SA completed the acquisition of selection of established products in Europe and Canada from Sanofi.	Jun. 04	CI
SANOFI : L’AMMC vise le prospectus relatif à l’augmentation de capital du groupe « SANOFI » réservée aux salariés du groupe	Jun. 04	PU
CAC40: further decline, W-Street heavier, 'WTI' below $73	Jun. 04	CF
CAC40: losses trimmed as oil falls below $78 and interest rates ease	Jun. 04	CF
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	Jun. 04	MT
SANOFI : UBS reiterates its Buy rating	Jun. 04	ZD
Sanofi: positive phase III data in myeloma	Jun. 04	CF
Sanofi's Blood Cancer Drug Sarclisa Meets Primary, Secondary Endpoints in Phase 3 Trial	Jun. 04	MT
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3	Jun. 03	GL
Sanofi - Dupixent recommended for EU approval by the CHMP to treat patients with COPD	Jun. 03	AQ
DHL Strikes Logistics Partnership with Sanofi	Jun. 03	MT
SANOFI : Gets a Neutral rating from JP Morgan	Jun. 03	ZD
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to proceed	Jun. 03	RE
Sanofi Enlists Banks for EUR20 Billion Consumer Health Spinoff, IPO	Jun. 03	MT
GSK Plans Appeal Against US Judge's Ruling on Jury Trials for Zantac Cases	Jun. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST